To include your compound in the COVID-19 Resource Center, submit it here.

Gilead beats Street EPS

GILD reported second quarter EPS of $0.46, beating the Street consensus by $0.02 and up 360% from EPS of $0.10 in the second quarter of 2002.

Read the full 264 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE